Answers are grounded in this paper and cite their sources.
Changes in the 2010 American Joint Commission on Cancer melanoma staging guidelines include the evaluation of primary tumor mitotic index (mitogenicity) and the recognized prognostic significance of a single melanoma cell in a sentinel lymph node. These revised criteria have important practice implications for dermatopathologists as well as for dermatologists, oncologists and surgeons who treat patients with cutaneous melanoma. Piris A, Mihm MC Jr, Duncan LM. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
No takes yet. Share an insight, caveat, or question.
Piris et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: